165 related articles for article (PubMed ID: 11567807)
1. Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques.
Jen YM; Hsu WL; Chen CY; Hwang JM; Chang LP; Lin YS; Su WF; Chen CM; Liu DW; Chao HL
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):344-8. PubMed ID: 11567807
[TBL] [Abstract][Full Text] [Related]
2. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?
Jen YM; Lin YS; Su WF; Hsu WL; Hwang JM; Chao HL; Liu DW; Chen CM; Lin HY; Wu CJ; Chang LP; Shueng PW
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):14-22. PubMed ID: 12182970
[TBL] [Abstract][Full Text] [Related]
3. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications.
Teo PM; Leung SF; Chan AT; Leung TW; Choi PH; Kwan WH; Lee WY; Chau RM; Yu PK; Johnson PJ
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1311-22. PubMed ID: 11121628
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time.
Lee AW; Kwong DL; Leung SF; Tung SY; Sze WM; Sham JS; Teo PM; Leung TW; Wu PM; Chappell R; Peters LJ; Fowler JF
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):75-85. PubMed ID: 12007944
[TBL] [Abstract][Full Text] [Related]
5. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy.
Mandell LR; Kadota R; Freeman C; Douglass EC; Fontanesi J; Cohen ME; Kovnar E; Burger P; Sanford RA; Kepner J; Friedman H; Kun LE
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):959-64. PubMed ID: 10192340
[TBL] [Abstract][Full Text] [Related]
6. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma.
Lee AW; Foo W; Chappell R; Fowler JF; Sze WM; Poon YF; Law SC; Ng SH; O SK; Tung SY; Lau WH; Ho JH
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):35-42. PubMed ID: 9422555
[TBL] [Abstract][Full Text] [Related]
7. [Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].
Lin SJ; Pan JJ; Wu JX; Han L; Pan CZ
Ai Zheng; 2007 Feb; 26(2):208-11. PubMed ID: 17298755
[TBL] [Abstract][Full Text] [Related]
8. Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF).
He XY; Liu TF; He SQ; Huan SL; Pan ZQ
Radiother Oncol; 2007 Oct; 85(1):29-35. PubMed ID: 17889386
[TBL] [Abstract][Full Text] [Related]
9. A phase III study of late course accelerated hyperfractionated radiotherapy versus conventionally fractionated radiotherapy in patients with nasopharyngeal carcinoma.
Pan ZQ; He XY; Guo XM; Ye M; Zhang Z; He SQ; Liu TF
Am J Clin Oncol; 2012 Dec; 35(6):600-5. PubMed ID: 22134512
[TBL] [Abstract][Full Text] [Related]
10. Fractionated stereotactic radiotherapy with vagina carotica protection technique for local residual nasopharyngeal carcinoma after primary radiotherapy.
Liu F; Xiao JP; Xu YJ; Zhang Y; Xu GZ; Gao L; Yi JL; Luo JW; Huang XD; Huan FK; Fang H; Wan B; Li YX
Chin Med J (Engl); 2012 Jul; 125(14):2525-9. PubMed ID: 22882934
[TBL] [Abstract][Full Text] [Related]
11. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients.
Jereczek-Fossa BA; Morra A; DeBraud F; Alterio D; Mazzetta C; Rocca A; Catalano G; Bianchi L; Pasetti M; Chiesa F; Bruschini R; Orecchia R
Strahlenther Onkol; 2004 Jul; 180(7):425-33. PubMed ID: 15241530
[TBL] [Abstract][Full Text] [Related]
12. [Accelerated fractionated radiotherapy with concurrent chemotherapy in advanced nasopharyngeal carcinoma].
Wang RS; Liu WQ; Li J; Zhang Y; Qin YT
Ai Zheng; 2003 Sep; 22(9):982-4. PubMed ID: 12969534
[TBL] [Abstract][Full Text] [Related]
13. Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors.
Choi KN; Rotman M; Aziz H; Sohn CK; Schulsinger A; Torres C; Har-El G; Chandra P; Bradley T; Rosenthal CJ
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):823-9. PubMed ID: 9369129
[TBL] [Abstract][Full Text] [Related]
14. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx.
Wendt CD; Peters LJ; Ang KK; Morrison WH; Maor MH; Goepfert H; Oswald MJ
Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1057-62. PubMed ID: 2808039
[TBL] [Abstract][Full Text] [Related]
15. Diffusion Kurtosis as an in vivo Imaging Marker of Early Radiation-Induced Changes in Radiation-Induced Temporal Lobe Necrosis in Nasopharyngeal Carcinoma Patients.
Liyan L; Si W; Qian W; Yuhui S; Xiaoer W; Yuehua L; Wenbin L
Clin Neuroradiol; 2018 Sep; 28(3):413-420. PubMed ID: 28447147
[TBL] [Abstract][Full Text] [Related]
16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601).
Tsuchiya S; Ohe Y; Sugiura T; Fuwa N; Kitamoto Y; Mori K; Kobayashi H; Nakata K; Sawa T; Hirai K; Etoh T; Saka H; Saito A; Fukuda H; Ishizuka N; Saijo N;
Jpn J Clin Oncol; 2001 Oct; 31(10):488-94. PubMed ID: 11696618
[TBL] [Abstract][Full Text] [Related]
18. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial.
Packer RJ; Boyett JM; Zimmerman RA; Albright AL; Kaplan AM; Rorke LB; Selch MT; Cherlow JM; Finlay JL; Wara WM
Cancer; 1994 Sep; 74(6):1827-34. PubMed ID: 8082086
[TBL] [Abstract][Full Text] [Related]
19. 1H-MR spectroscopy and diffusion tensor imaging of normal-appearing temporal white matter in patients with nasopharyngeal carcinoma after irradiation: initial experience.
Xiong WF; Qiu SJ; Wang HZ; Lv XF
J Magn Reson Imaging; 2013 Jan; 37(1):101-8. PubMed ID: 22972703
[TBL] [Abstract][Full Text] [Related]
20. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
